<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02269800</url>
  </required_header>
  <id_info>
    <org_study_id>LST-001</org_study_id>
    <nct_id>NCT02269800</nct_id>
  </id_info>
  <brief_title>An Efficacy Study of BCS Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD</brief_title>
  <official_title>An Efficacy Study of Benzalkonium Chloride Solution Clearing the Oral Colonized Bacterium in Hospitalized Patients With COPD</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lustre Pharmaceutical Lab Co., Ltd</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Lustre Pharmaceutical Lab Co., Ltd</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of study is to evaluate the efficacy and safety of Benzalkonium Chloride Solution
      clearing the oral colonized bacterium in hospitalized patients with COPD.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This a randomized, double-blind, parallel, single-center, exploratory trial. 60 patients will
      be randomized to two treatments: benzalkonium chloride solution treatment or normal saline
      treatment.The purpose of study is to evaluate the efficacy and safety of benzalkonium
      chloride solution clearing the oral colonized bacterium in hospitalized patients with COPD.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2014</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">July 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Aerobic pathogenic bacterial colonization rate in oral airway</measure>
    <time_frame>Day 7</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The improvement of oral status</measure>
    <time_frame>Day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The subjective feeling</measure>
    <time_frame>Day 7</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The incidence of hospital acquired respiratory infections</measure>
    <time_frame>Day 7</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Benzalkonium chloride solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tid, for 7 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Tid, for 7 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzalkonium chloride solution</intervention_name>
    <description>Tid, 7 days</description>
    <arm_group_label>Benzalkonium chloride solution</arm_group_label>
    <other_name>You Ke Shi</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>Tid, 7 days</description>
    <arm_group_label>Normal saline</arm_group_label>
    <other_name>NS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. COPD patients in hospitalized.

          2. Aged from18 to 70 years (including 18 and 70).

          3. Patients participating in this trial should sign ICFs.

          4. Patients with good understanding, could conduct this study with investigators.

        Exclusion Criteria:

          1. History of mouthwash allergies, allergic rhinitis or dermatitis.

          2. Patients with oral ulcers, severe periodontal disease, oral mucosal lesions or oral
             cancer, patients received special oral clean.

          3. Patients with removable denture.

          4. Patients with malignant blood diseases.

          5. History of using cytotoxic drugs or biological immunosuppressants ( such as TNF-Î±
             inhibitors ).

          6. Had used clinical study drugs before 28 days enrollment.

          7. Had used clinical study drugs before 28 days enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shiyue Li, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>The First Affiliated Hospital of Guangzhou Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shiyue Li, Professor</last_name>
    <phone>86 20 83062885</phone>
    <email>lishiyue@188.com</email>
  </overall_contact>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 17, 2014</study_first_submitted>
  <study_first_submitted_qc>October 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 21, 2014</study_first_posted>
  <last_update_submitted>October 17, 2014</last_update_submitted>
  <last_update_submitted_qc>October 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 21, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
    <mesh_term>Benzalkonium Compounds</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

